Opinion
News Analysis
Economics of Aging
Longevity
Aging Well
Tom Kirkwood
Bioethics
Investor Profile
Reviews
Metrics
Case Studies
Synopses
Photo Essay
In Every Issue
Editor's Letter


Double Attack

A new kind of high-throughput screening may truly make drugs better, faster, cheaper.

Although physicians and pharmaceutical scientists often combine drugs when a benefit is predictable, until now, scientists had no reliable means of testing possible combinations—nor, indeed, any compelling reason to do so. In June, however, researchers at CombinatoRx published a paper in the Proceedings of the National Academy of Sciences demonstrating not only how drug combinations can be tested systematically, but also that some may have surprisingly therapeutic benefits.1

News Analysis

Ready or Not

Vive la Differentiation!

Shrinking Staffs

» Double Attack

Bull’s-Eye?

Biotech Buys

Sniffing for SNPs

1 Borisy, A.A., et al. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences U.S.A. 100:7977–82.